Recall of Medtronic embolization devices classified as most serious by USFDA
Medtronic's recall of embolization device has been classified most serious by the U.S. Food and Drug Administration (USFDA), citing potential risks of severe injury or death. This decision follows the reports of four patient fatalities.
As per the USFDA, the affected product could lead to risk of severe adverse health consequences, including thrombosis, stroke, or death.
Thirteen injuries have been reported in connection with the use of the devices known as Pipeline Vantage Embolization devices.
The recall impacts the Pipeline Vantage devices compatible only with 0.027" inner diameter microcatheters, Medtronic said. The company added that it has taken the necessary steps to retrieve the recalled products and has notified regulatory agencies globally as appropriate.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.